Keyphrases
Beneficial Effects
100%
Care Pathway
25%
Chemotherapy
50%
Clinical Care Pathway
100%
Collaborative Care
25%
Complication Rate
25%
Germ Cell Carcinoma
50%
Hospital Stay
75%
Nasogastric Tube
25%
Pathological Stage
25%
Pathway Prototyping
100%
Perioperative Care
25%
Post-chemotherapy Retroperitoneal Lymph Node Dissection
25%
Postoperative Care
50%
Postoperative Outcomes
25%
Primary Chemotherapy
25%
Retroperitoneal Lymph Node Dissection (RPLND)
100%
Testicular Cancer
100%
Nursing and Health Professions
Care Pathway
100%
Collaborative Care
20%
Germ Cell Carcinoma
40%
Hospitalization
60%
Lymph Node Dissection
100%
Nasogastric Tube
20%
Perioperative Period
20%
Postoperative Care
40%
Testis Cancer
100%
Medicine and Dentistry
Care Pathway
100%
Germ Cell Carcinoma
40%
Perioperative Period
20%
Postoperative Care
40%
Retroperitoneal Lymph Node Dissection
100%
Testis Cancer
100%